| 1 |
35448460 | L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact. | 2022 Mar 22 |
2 |
| 2 |
35448538 | Untargeted Metabolomics of Slc13a5 Deficiency Reveal Critical Liver-Brain Axis for Lipid Homeostasis. | 2022 Apr 14 |
1 |
| 3 |
33544126 | Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier. | 2021 Feb 12 |
4 |
| 4 |
33597751 | Structure and inhibition mechanism of the human citrate transporter NaCT. | 2021 Mar |
4 |
| 5 |
34101804 | A home run for human NaCT/SLC13A5/INDY: cryo-EM structure and homology model to predict transport mechanisms, inhibitor interactions and mutational defects. | 2021 Jun 11 |
2 |
| 6 |
34323067 | Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD. | 2021 Aug 11 |
3 |
| 7 |
34525352 | NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions. | 2021 Sep 14 |
4 |
| 8 |
34677384 | Drosophila INDY and Mammalian INDY: Major Differences in Transport Mechanism and Structural Features despite Mostly Similar Biological Functions. | 2021 Sep 29 |
2 |
| 9 |
34677420 | Molecular Mechanisms of the SLC13A5 Gene Transcription. | 2021 Oct 15 |
2 |
| 10 |
34943889 | Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes. | 2021 Dec 1 |
2 |
| 11 |
32444674 | The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin. | 2020 May 22 |
1 |
| 12 |
32634519 | Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells. | 2020 Sep 1 |
2 |
| 13 |
32692565 | Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism. | 2020 Sep 4 |
1 |
| 14 |
33079129 | Functional analysis of a species-specific inhibitor selective for human Na+-coupled citrate transporter (NaCT/SLC13A5/mINDY). | 2020 Nov 13 |
2 |
| 15 |
29410496 | Identification of a novel Na+-coupled Fe3+-citrate transport system, distinct from mammalian INDY, for uptake of citrate in mammalian cells. | 2018 Feb 6 |
4 |
| 16 |
30054523 | Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism. | 2018 Jul 27 |
2 |
| 17 |
30478052 | Citrate-based materials fuel human stem cells by metabonegenic regulation. | 2018 Dec 11 |
2 |
| 18 |
28264506 | Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy. | 2017 Feb 28 |
9 |
| 19 |
28655760 | Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells. | 2017 Aug 18 |
3 |
| 20 |
28673551 | Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle. | 2017 Aug |
3 |
| 21 |
28821606 | Flipping a citrate switch on liver cancer cells. | 2017 Aug 18 |
1 |
| 22 |
26734723 | Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family. | 2016 Feb 11 |
1 |
| 23 |
27069776 | Model-Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target. | 2016 Mar |
3 |
| 24 |
27683012 | Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors. | 2016 Dec |
2 |
| 25 |
27754898 | State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281. | 2016 Dec |
2 |
| 26 |
27818933 | Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. | 2016 Nov |
1 |
| 27 |
25617245 | Species-specific influence of lithium on the activity of SLC13A5 (NaCT): lithium-induced activation is specific for the transporter in primates. | 2015 Apr |
1 |
| 28 |
25628225 | SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. | 2015 Apr |
2 |
| 29 |
26303333 | Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes. | 2015 Nov 4 |
2 |
| 30 |
26324167 | Electrophysiological characterization of human and mouse sodium-dependent citrate transporters (NaCT/SLC13A5) reveal species differences with respect to substrate sensitivity and cation dependence. | 2015 Nov |
4 |
| 31 |
26384929 | Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. | 2015 Nov |
1 |
| 32 |
26620127 | Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). | 2015 Dec 1 |
4 |
| 33 |
24995870 | Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. | 2014 Jul 3 |
1 |
| 34 |
24688728 | The Role of INDY in Metabolic Regulation. | 2013 |
1 |
| 35 |
16973915 | Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines. | 2007 Jan |
1 |
| 36 |
12826022 | Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium action. | 2003 Aug 15 |
2 |